Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 1
2000 1
2001 1
2002 1
2009 1
2010 1
2011 1
2012 3
2013 2
2014 2
2015 2
2016 2
2017 3
2018 3
2019 5
2020 4
2021 5
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Cost-effectiveness of lenalidomide.
Olry de Labry Lima A, Matas Hoces A, Gimeno Ballester V, Ríos Sánchez E, Alegre Del Rey EJ. Olry de Labry Lima A, et al. Among authors: alegre del rey ej. Bone Marrow Transplant. 2020 May;55(5):853-854. doi: 10.1038/s41409-020-0787-7. Epub 2020 Jan 22. Bone Marrow Transplant. 2020. PMID: 31969679 Free article. No abstract available.
[Indirect comparisons].
Ortega Eslava A, Fraga Fuentes MD, Alegre Del Rey EJ, Ventayol Bosch P. Ortega Eslava A, et al. Among authors: alegre del rey ej. Farm Hosp. 2012 Jul-Aug;36(4):173-5. doi: 10.1016/j.farma.2011.06.007. Epub 2012 Jan 17. Farm Hosp. 2012. PMID: 22257629 Free article. Spanish. No abstract available.
Cost-effectiveness of Evolocumab. Response.
Olry de Labry Lima A, Matas Hoces A, Alegre Del Rey EJ, Gimeno Ballester V. Olry de Labry Lima A, et al. Among authors: alegre del rey ej. Rev Esp Cardiol (Engl Ed). 2018 Dec;71(12):1090. doi: 10.1016/j.rec.2018.05.031. Epub 2018 Aug 8. Rev Esp Cardiol (Engl Ed). 2018. PMID: 30098932 English, Spanish. No abstract available.
Pembrolizumab plus Chemotherapy in Lung Cancer.
Gil-Sierra MD, Fenix-Caballero S, Alegre-del Rey E. Gil-Sierra MD, et al. Among authors: alegre del rey e. N Engl J Med. 2018 Sep 13;379(11):e18. doi: 10.1056/NEJMc1808567. N Engl J Med. 2018. PMID: 30211498 No abstract available.
Nivolumab and Ipilimumab in Advanced Melanoma.
Alegre-del-Rey EJ, de la Nogal Fernández B, Briceño-Casado P. Alegre-del-Rey EJ, et al. N Engl J Med. 2017 Dec 21;377(25):2503. doi: 10.1056/NEJMc1714339. N Engl J Med. 2017. PMID: 29265786 No abstract available.
Indirect comparison of biological treatments in refractory rheumatoid arthritis.
Gallego-Galisteo M, Villa-Rubio A, Alegre-del Rey E, Márquez-Fernández E, Ramos-Báez JJ. Gallego-Galisteo M, et al. Among authors: alegre del rey e. J Clin Pharm Ther. 2012 Jun;37(3):301-7. doi: 10.1111/j.1365-2710.2011.01292.x. Epub 2011 Aug 10. J Clin Pharm Ther. 2012. PMID: 21831256 Review.
[Therapeutic alternatives equivalent: in the eye of the hurricane].
López Briz E, Alegre del Rey E, Fraga Fuentes MD, Clopés Esela A, Bautista Paloma J, Ortega Eslava A; Grupo GENESIS de la Sociedad Española de Farmacia Hospitalaria. López Briz E, et al. Among authors: alegre del rey e. Farm Hosp. 2013 Jul-Aug;37(4):273-5. doi: 10.7399/FH.2013.37.4.760. Farm Hosp. 2013. PMID: 24010687 Free article. Spanish. No abstract available.
Checklist for clinical applicability of subgroup analysis.
Gil-Sierra MD, Fénix-Caballero S, Abdel Kader-Martin L, Fraga-Fuentes MD, Sánchez-Hidalgo M, Alarcón de la Lastra-Romero C, Alegre-Del Rey EJ. Gil-Sierra MD, et al. Among authors: alegre del rey ej. J Clin Pharm Ther. 2020 Jun;45(3):530-538. doi: 10.1111/jcpt.13102. Epub 2019 Dec 18. J Clin Pharm Ther. 2020. PMID: 31854128
43 results